Hypoparathyroidism

E4_HYPOPARA

hypoparathyroidism: Hypoparathyroidism is is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (PTH). Common signs and symptoms includeabdominal pain, brittle nails, cataracts, dry hair and skin,muscle cramps,tetany, pain in the face, legs, and feet, seizures, tingling sensation,and weakened tooth enamel (in children). It may be caused byinjury to the parathyroid glands (e.g., during surgery). Other causes, include low blood magnesium levels, a side effect of radioactive iodine treatment for hyperthyroidism , metabolic alkalosis , DiGeorge syndrome , and type I polyglandular autoimmune syndrome . The goal of treatment is to restore the calcium and mineral balance in the body.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E20 Hospital discharge: ICD-9 — 2521 Hospital discharge: ICD-8 — 2521 Cause of death: ICD-10 — E20 Cause of death: ICD-9 — 2521 Cause of death: ICD-8 — 2521 KELA reimbursements: KELA codes — 106 Medicine purchases: ATC — H05AA 4 out of 7 registries used, show all original rules.	1362
4. Check minimum number of events Min. number of events 3	1362
5. Include endpoints None	1362
6. Filter based on genotype QC (FinnGen only)	1326

Control definitions (FinnGen only)

Control exclude: E4_ENDOGLAND

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E20-E35
Name in latin: Hypoparathyreoidismus

NAME	E4_HYPOPARA
CONTROL_EXCLUDE	E4_ENDOGLAND
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E20
HD_ICD_9	2521
HD_ICD_8	2521
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E20
COD_ICD_9	2521
COD_ICD_8	2521
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	106
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	H05AA
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypoparathyroidism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	8240	6591	1583
Only index persons	6794	5561	1233
Unadjusted period prevalence (%)
Whole population	0.16	0.19	0.04
Only index persons	0.18	0.20	0.05
Median age at first event (years)
Whole population	60.83	61.53	57.93
Only index persons	60.57	61.51	56.35

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1326	1064	262
Unadjusted period prevalence (%)	0.33	0.38	0.12
Median age at first event (years)	60.29	60.48	59.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1361: Matched controls
13610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

104

Kela drug reimbursment

Thyroid insufficiency

9.8

318.3

459

675

318

Kela drug reimbursment

Teriparatide

3894.0

307.7

607

H05AA02

ATC

teriparatide; parenteral

3935.4

307.7

610

106

Kela drug reimbursment

Hypoparathyroidism

+∞

307.7

525

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

349.1

307.7

278

E83.51

ICD-10 Finland

Hypocalcemia

100.0

307.7

197

A11CC03

ATC

alfacalcidol; systemic

75.0

307.7

429

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

113.6

307.7

195

A12AA04

ATC

calcium carbonate; oral

144.7

307.7

362

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

37.1

307.7

277

BAA60

NOMESCO Finland

Total thyroidectomy

20.0

303.7

247

149

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

16.7

297.5

268

197

M05BX04

ATC

denosumab; parenteral

9.9

294.7

406

561

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

9.6

271.8

377

522

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

20.2

271.7

218

127

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

7.5

258.2

1038

4069

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

16.7

243.3

215

151

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

28.4

236.8

163

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

30.2

232.2

156

A11CC02

ATC

dihydrotachysterol; oral

644.7

226.5

218

L95

ICPC

Osteoporosis

9.8

212.5

275

344

M81.9

ICD-10 Finland

Osteoporosis, unspecified

8.2

186.1

278

411

M05BA04

ATC

alendronic acid; oral

5.9

178.7

402

900

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

1868.6

168.3

160

A12AA06

ATC

calcium lactate gluconate; oral

+∞

147.6

139

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.3

144.1

354

844

H02AB09

ATC

hydrocortisone; systemic

17.4

143.8

121

H03AA01

ATC

levothyroxine sodium; systemic

4.0

139.1

665

2616

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

11.4

138.5

151

147

M05BA07

ATC

risedronic acid; oral

8.0

127.8

186

263

E20.8

ICD-10 Finland

Other hypoparathyroidism

+∞

118.5

112

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

+∞

117.4

111

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

66.0

114.3

E21.0

ICD-10 Finland

Primary hyperparathyroidism

51.6

110.9

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

243.8

110.5

112

L04AX01

ATC

azathioprine; systemic

7.6

105.8

160

235

M81.4

ICD-10 Finland

Drug-induced osteoporosis

44.0

105.4

L01BA01

ATC

methotrexate; systemic

6.6

87.6

151

254

E83.50

ICD-10 Finland

Hypercalcemia

16.0

84.2

M80

ICD-10 Finland

Osteoporosis with pathological fracture

15.6

84.1

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

46.2

82.9

EP1AE

NOMESCO Finland

Neck ultrasound examination

5.2

80.7

183

397

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

31.1

77.6

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

5.9

76.6

147

274

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

73.8

370

1408

L04AX03

ATC

methotrexate; systemic

3.8

73.3

260

793

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

3.6

73.1

291

959

L88

ICPC

Rheumatoid/seropositive arthritis

5.5

70.9

146

290

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

10.0

70.1

L04AA13

ATC

[U] leflunomide

7.2

69.5

108

162

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

4.4

65.7

181

458

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.5

62.7

107

177

P01BA02

ATC

hydroxychloroquine; oral

3.6

62.5

234

736

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

5.6

62.3

125

242

M05BX03

ATC

strontium ranelate; oral

15.0

61.6

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

59.6

796

4880

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.3

57.8

101

171

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

4.0

57.4

178

490

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.9

57.3

186

529

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

5.0

57.1

132

289

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

+∞

55.6

L04AA01

ATC

[U] ciclosporin

11.2

55.1

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

7.4

54.2

116

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

6.2

54.1

165

L04AA06

ATC

mycophenolic acid; systemic

10.2

52.8

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

9.5

52.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

50.7

580

3248

127

Kela drug reimbursment

Transplant complication

13.4

50.5

X59

ICD-10 Finland

Exposure to unspecified factor

2.7

49.8

344

1524

M81.8

ICD-10 Finland

Other osteoporosis

11.5

49.5

H02AB06

ATC

prednisolone; systemic

2.3

49.5

782

5006

NF1AA

NOMESCO Finland

Hip X-ray examination

3.2

49.1

221

774

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

48.4

354

1610

C03CA01

ATC

furosemide; systemic

2.3

47.7

554

3104

N02AA05

ATC

oxycodone; systemic

2.6

47.5

354

1623

ZX120

NOMESCO Finland

Intravenous

3.2

46.9

210

732

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.3

46.6

202

691

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

10.2

46.5

N02AX02

ATC

tramadol; systemic, rectal

2.2

45.9

691

4291

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

5.7

45.3

161

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.3

45.1

187

622

SPAT1262

SPAT

Handing over of treatment supplies

2.5

42.6

324

1491

M05BA06

ATC

ibandronic acid; systemic

5.2

42.5

186

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

430.5

42.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

41.3

268

1140

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

41.3

434

2304

SPAT1229

SPAT

Assessment of need for aid

3.1

41.2

189

666

J01FF01

ATC

clindamycin; systemic

2.3

40.5

455

2478

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

5.5

40.4

156

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

7.8

40.1

M01CB01

ATC

sodium aurothiomalate; parenteral

7.3

39.6

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.9

39.4

121

329

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

15.8

39.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

39.0

518

3008

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

205.9

39.0

L04AB01

ATC

etanercept; parenteral

7.9

38.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

38.4

215

845

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

38.2

380

1961

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

37.7

J01MA12

ATC

levofloxacin; systemic

2.4

37.7

317

1520

L04AD01

ATC

ciclosporin; systemic

7.3

37.5

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

36.9

393

2082

L28

ICPC

Limited function/disability (L)

2.3

36.8

352

1782

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

35.8

238

1020

N03AX16

ATC

[U] pregabalin

2.2

35.7

414

2265

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.5

35.6

211

H02AB04

ATC

methylprednisolone; systemic

2.5

35.4

271

1241

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.0

35.1

657

4289

S97

ICPC

Chronic ulcer skin

3.4

35.1

136

431

M81.5

ICD-10 Finland

Idiopathic osteoporosis

8.9

35.0

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

5.2

34.9

146

L76

ICPC

Fracture: other

4.4

34.7

211

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

+∞

34.5

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.7

34.4

208

849

H26.3

ICD-10 Finland

Drug-induced cataract

12.4

34.2

NF3AA

NOMESCO Finland

Femur X-ray examination

5.3

34.2

141

3025

Kela drug reimbursment

Calcium carbonate

46.9

33.9

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

39.4

33.5

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.8

33.5

186

726

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.2

33.4

396

2176

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

57.3

33.4

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

4.5

32.6

187

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

32.6

271

1284

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

6.8

32.1

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

31.9

219

950

GD1AD

NOMESCO Finland

Thorax CT examination

3.4

31.7

123

390

E20

ICD-10 Finland

Hypoparathyroidism

+∞

31.4

ZXD05

NOMESCO Finland

Urgent procedure

2.0

31.2

459

2723

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

31.2

300

1511

SPAT1254

SPAT

Administration of medicine

2.3

31.1

273

1323

ZZH31

NOMESCO Finland

Bone allograft, small pieces

9.5

31.0

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.0

31.0

145

514

M05BA01

ATC

etidronic acid; systemic

9.7

30.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

30.3

118

375

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.7

30.3

101

290

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

33.4

30.1

A07EC01

ATC

sulfasalazine; oral, rectal

2.8

30.1

160

609

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

4.1

30.0

222

H02AB07

ATC

prednisone; oral

2.3

29.8

256

1227

N03AX12

ATC

[U] gabapentin; oral

2.2

29.8

296

1508

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

29.6

190

796

NFJ60

NOMESCO Finland

Internal fixation of fracture of other parts of femur with intramedullary nail

9.9

29.5

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.7

29.4

286

WZC00

NOMESCO Finland

Treatment plan or consultation

1.9

29.3

550

3532

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

29.2

155

589

AA1AD

NOMESCO Finland

CT of head and brain

2.0

29.2

448

2686

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

29.1

222

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

7.9

29.0

H02AA02

ATC

fludrocortisone; oral

9.9

28.6

M54.5

ICD-10 Finland

Low back pain

1.9

28.5

554

3590

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

6.4

28.0

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

4.8

28.0

142

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.7

27.8

170

694

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.0

27.7

212

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

27.7

557

3643

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

3.4

27.7

105

328

L04AB04

ATC

adalimumab; parenteral

5.4

27.6

105

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.2

27.4

187

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

4.1

27.3

196

S72.3

ICD-10 Finland

Fracture of shaft of femur

7.8

27.3

X58

ICD-10 Finland

Exposure to other specified factors

2.4

27.2

224

1052

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

9.6

27.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.9

27.0

138

513

XG410

NOMESCO Finland

Flow-volume spirometry

3.8

27.0

239

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

27.0

482

3026

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

26.9

609

4126

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

276.3

26.8

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

28.4

26.8

105

Kela drug reimbursment

Adrenal cortical hypofunction

+∞

26.1

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

74.2

25.9

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

265.5

25.8

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

25.8

221

1054

W19

ICD-10 Finland

Unspecified fall

2.5

25.6

177

766

R50.9

ICD-10 Finland

Fever, unspecified

2.2

25.6

240

1188

S72.2

ICD-10 Finland

Subtrochanteric fracture

9.6

25.4

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

4.1

25.0

173

A07AA02

ATC

nystatin; oral

2.9

25.0

129

482

E0000UV, ,

ATC

1.8

25.0

622

4309

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

6.0

24.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

24.5

646

4543

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

4.9

24.5

117

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

24.4

203

954

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

22.4

24.4

H03BB01

ATC

carbimazole; oral

3.3

24.1

309

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

24.1

108

373

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.9

24.0

119

435

SPAT1255

SPAT

Intravenous administration of medicine

2.8

23.9

124

464

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

23.9

106

364

A46

ICD-10 Finland

Erysipelas

2.2

23.8

225

1115

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

88.4

23.7

J46

ICD-10 Finland

Status asthmaticus

4.2

23.7

162

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

23.7

132

513

ZXA10

NOMESCO Finland

Bilateral

2.0

23.6

323

1839

L03

ICPC

Low back symptom/complaint

1.9

23.6

440

2776

A02BC05

ATC

esomeprazole; systemic

1.8

23.6

615

4295

5BA08, ,

NOMESCO Finland

9.5

23.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

23.5

141

569

UJF32

NOMESCO Finland

Coloscopy

1.9

23.4

415

2576

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

23.4

278

1505

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.9

23.4

191

NH3EA

NOMESCO Finland

Feet X-ray examination with load

4.9

23.3

110

R03BB04

ATC

tiotropium bromide; inhalant

2.4

23.3

170

754

2506

FHL

Thyroidectomy

28.8

23.2

ND1AA

NOMESCO Finland

Wrist X-ray examination

2.6

23.1

145

598

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.5

23.1

245

A02BC02

ATC

pantoprazole; systemic

1.9

23.1

981

7891

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

23.0

139

563

25219

ICD-8 Finland

Diseases of parathyroid gland, Hypoparathyreoidismus alius sive NUD

+∞

23.0

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.7

22.9

208

NH1AD

NOMESCO Finland

Ankle and foot CT

4.8

22.8

112

WZC30

NOMESCO Finland

Teaching

2.1

22.6

257

1367

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

22.6

273

1485

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.3

22.6

269

J01MA02

ATC

ciprofloxacin; systemic

1.8

22.6

556

3806

S52.0

ICD-10 Finland

Fracture of upper end of ulna

4.9

22.6

105

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

22.4

420

2647

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

22.3

357

2140

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.5

22.1

127

R06.0

ICD-10 Finland

Dyspnoea

1.8

22.1

425

2697

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.8

22.1

107

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

3.0

21.8

101

355

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

7.0

21.7

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

4.5

21.7

125

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

21.6

250

1336

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.2

21.5

147

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

21.4

148

639

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

21.4

180

848

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

21.1

21.3

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.3

21.2

259

R13

ICD-10 Finland

Dysphagia

2.6

21.1

131

537

TK800

NOMESCO Finland

Hemodialysis

6.4

21.1

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.8

21.0

177

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

+∞

20.9

SPAT1301

SPAT

No procedures

1.8

20.7

481

3217

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

20.6

143

A28

ICPC

Limited function/disability NOS

1.9

20.6

299

1729

A06AD11

ATC

lactulose; oral

2.0

20.6

247

1337

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.6

20.5

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.5

20.5

141

607

J01DB01

ATC

cefalexin; oral

2.0

20.5

1133

9686

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

20.4

308

1803

R53

ICD-10 Finland

Malaise and fatigue

1.8

20.4

371

2306

A07AA09

ATC

vancomycin; oral

5.5

20.3

ZX114

NOMESCO Finland

Intramuscular

5.5

20.3

SPAT1263

SPAT

Sampling

1.7

20.2

609

4375

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

20.2

151

676

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

3.8

20.1

173

B01AB05

ATC

enoxaparin; parenteral

1.7

20.1

485

3275

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.9

20.1

338

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

5.0

20.0

J45.8

ICD-10 Finland

Mixed asthma

3.6

19.8

189

NDG30

NOMESCO Finland

Fusion of wrist, total

8.3

19.7

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

19.7

182

891

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

106.6

19.6

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.9

19.5

355

S18

ICPC

Laceration/cut

1.7

19.4

653

4814

E87.6

ICD-10 Finland

Hypokalaemia

3.2

19.3

258

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

19.3

120

492

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

5.4

19.3

E21.2

ICD-10 Finland

Other hyperparathyroidism

46.7

19.2

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

17.0

19.2

SPAT1211

SPAT

Application of soft bandage

2.3

19.2

153

704

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

20.4

19.1

SPAT1216

SPAT

Assessment of functional ability

1.9

19.1

273

1567

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

19.1

192

971

Z3226

NOMESCO Finland

Physiotherapist

1.9

19.0

288

1684

N18.8

ICD-10 Finland

Other chronic renal failure

4.6

19.0

100

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

19.0

198

1015

R03AK08

ATC

formoterol and beclometasone; inhalant

3.0

19.0

293

NFU20

NOMESCO Finland

Removal of internal fixation device from femur

6.3

19.0

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.9

18.7

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.3

18.7

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

18.6

687

5167

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

18.6

173

848

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

5.8

18.6

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.1

18.5

270

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

18.5

185

933

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.2

18.5

244

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

18.5

155

728

Z2446

NOMESCO Finland

Social worker

2.6

18.5

115

472

WX204

NOMESCO Finland

Axillary plexus blockaced

3.4

18.4

204

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.8

18.2

152

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.4

18.1

206

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.9

18.1

139

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

18.0

164

796

C03DA01

ATC

spironolactone; oral

2.1

18.0

191

984

A01AB09

ATC

miconazole; local oral

2.2

17.9

159

764

A41.9

ICD-10 Finland

Sepsis, unspecified

3.5

17.8

183

R4180

NOMESCO Finland

Podiatric therapy

5.7

17.8

SPAT1310

SPAT

Counselling related to known health issue

1.7

17.7

466

3196

101

Kela drug reimbursment

Anterior pituitary hypofunction

+∞

17.7

BBA20

NOMESCO Finland

Exploration of parathyroid gland

+∞

17.7

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

17.7

299

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

4.4

17.7

106

RD210, ,

NOMESCO Finland

5.0

17.6

S22.3

ICD-10 Finland

Fracture of rib

2.6

17.5

110

453

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

17.4

171

NFJ62

NOMESCO Finland

Internal fixation of fracture of other parts of femur with plate

7.1

17.4

L17

ICPC

Foot/toe symptom/complaint

1.7

17.4

437

2958

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

17.3

267

1566

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.0

17.2

271

Z94.0

ICD-10 Finland

Kidney transplant status

15.0

17.2

S32.5

ICD-10 Finland

Fracture of pubis

6.5

17.1

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

5.6

17.0

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.0

17.0

127

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

4.2

16.9

110

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.9

16.8

280

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

16.7

238

1359

BBA50

NOMESCO Finland

Total parathyroidectomy

+∞

16.7

E31.00

ICD-10 Finland

APECED syndrome

+∞

16.7

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

16.7

520

3716

S32.7

ICD-10 Finland

Multiple fractures of lumbar spine and pelvis

5.6

16.5

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

172.0

16.5

R11

ICD-10 Finland

Nausea and vomiting

2.2

16.5

152

741

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.8

16.5

139

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.8

16.5

139

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.2

16.4

SXC03

NOMESCO Finland

Other oral or dental procedure

5.8

16.4

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

4.2

16.4

104

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.5

16.3

110

469

XG466

NOMESCO Finland

Sleep oxymetry

3.7

16.3

145

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

16.2

220

1235

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

16.2

556

4059

J01MA14

ATC

moxifloxacin; systemic

2.2

16.2

140

665

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

16.2

581

4290

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

16.2

261

1551

N06AX21

ATC

duloxetine; oral

2.0

16.1

186

987

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

16.1

237

M54

ICD-10 Finland

Dorsalgia

2.0

16.1

187

995

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

5.8

15.9

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.2

15.9

102

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

15.9

155

773

WW200

NOMESCO Finland

Immunization

3.8

15.8

129

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

15.8

209

1163

J04AB02

ATC

rifampicin; systemic

5.9

15.8

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

7.0

15.7

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

15.7

138

660

N05CF01

ATC

zopiclone; oral

1.6

15.6

476

3370

X57

ICD-10 Finland

Unspecified privation

4.1

15.6

108

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

15.6

356

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

15.6

118

530

TQW80

NOMESCO Finland

Local dermatologic skincare

3.5

15.5

155

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

4.1

15.3

105

K50.9

ICD-10 Finland

Crohn disease, unspecified

5.1

15.3

N02BE01

ATC

paracetamol; systemic, rectal

2.1

15.3

1230

11100

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

15.2

366

EBA10

NOMESCO Finland

Operative extraction of tooth

2.1

15.1

152

766

A01

ICPC

Pain general/multiple sites

2.1

15.1

160

823

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.6

15.1

356

NHQ40

NOMESCO Finland

Amputation of toe

5.0

15.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

14.9

504

3647

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.0

14.9

190

1043

M48.0

ICD-10 Finland

Spinal stenosis

1.9

14.9

207

1170

L99

ICPC

Musculoskeletal disease other

3.7

14.9

130

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

14.9

278

1722

JN4CD

NOMESCO Finland

Very extensive body CT

3.0

14.8

222

M54.6

ICD-10 Finland

Pain in thoracic spine

2.3

14.8

116

529

Z3231

NOMESCO Finland

Registered nurse

1.7

14.7

385

2614

E23.03

ICD-10 Finland

Lack of ACTH

+∞

14.6

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

14.6

108

480

WZA10

NOMESCO Finland

Extensive medical or dental certificate

5.0

14.6

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.6

14.6

350

L75

ICPC

Fracture: femur

4.6

14.5

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.2

14.5

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

14.5

152

779

UJF30

NOMESCO Finland

Ileoscopy through colon

2.0

14.4

161

843

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

5.6

14.3

XF640, ,

NOMESCO Finland

3.3

14.3

163

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.4

14.3

158

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

14.3

124

589

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

27.5

14.3

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.7

14.3

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.8

14.2

272

WX002

NOMESCO Finland

Sedation and analgesia

1.7

14.2

289

1833

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.6

14.1

325

A02BA02

ATC

ranitidine; systemic

1.7

14.1

293

1867

327

Kela drug reimbursment

strontium ranelate

43.0

14.1

A10AB05

ATC

insulin aspart; parenteral

2.3

14.1

111

507

NB1AD

NOMESCO Finland

Shoulder CT examination

3.7

14.1

121

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

14.6

14.1

NB6AA

NOMESCO Finland

Humerus X-ray examination

3.3

14.1

165

M19.2

ICD-10 Finland

Other secondary arthrosis

4.7

14.0

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

5.5

14.0

S82.0

ICD-10 Finland

Fracture of patella

3.8

14.0

112

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

5.9

14.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

14.0

315

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.5

14.0

357

R03AC02

ATC

salbutamol; inhalant

1.6

14.0

756

6065

NCJ64

NOMESCO Finland

Other internal fixation of fracture of forearm

5.3

13.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

13.9

227

1348

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

3.0

13.9

203

B01AA03

ATC

warfarin; systemic

1.8

13.8

256

1579

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

13.8

283

1796

WX882

NOMESCO Finland

High dependency care

3.3

13.8

157

K22.2

ICD-10 Finland

Oesophageal obstruction

6.3

13.8

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

13.7

205

1185

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.8

13.7

114

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.3

13.7

ZZA00

NOMESCO Finland

Split skin graft

3.4

13.6

153

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.8

13.6

110

E23.00

ICD-10 Finland

Panhypopituitarism

+∞

13.6

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

5.9

13.5

R03DA04

ATC

theophylline; systemic, rectal

2.6

13.5

332

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

34.4

13.5

M13.9

ICD-10 Finland

Arthritis, unspecified

2.3

13.5

111

516

NDG74

NOMESCO Finland

Fusion of first IP joint

16.4

13.5

R52.2

ICD-10 Finland

Other chronic pain

2.8

13.4

263

R60.0

ICD-10 Finland

Localized oedema

1.9

13.4

189

1073

JN4BD

NOMESCO Finland

Extensive body CT

2.0

13.1

153

813

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.8

13.1

243

SPAT1153

SPAT

Removal of sutures

1.6

13.1

452

3267

L84

ICD-10 Finland

Corns and callosities

2.9

13.0

222

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.8

13.0

109

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.6

12.9

119

K07

ICPC

Swollen ankles/oedema

2.5

12.9

359

JN4AD

NOMESCO Finland

Body CT examination

2.0

12.8

144

755

N03AE01

ATC

clonazepam; systemic

2.4

12.8

397

SPAT1325

SPAT

Vaccination

1.6

12.8

484

3567

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.6

12.8

115

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.1

12.8

133

679

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

12.7

398

N05CD07

ATC

temazepam; oral

1.9

12.7

182

1036

A12BA01

ATC

potassium chloride; oral

2.5

12.7

324

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

12.7

106

TQW40

NOMESCO Finland

Remowal of suture of skin

2.2

12.7

112

536

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.0

12.6

152

817

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

6.0

12.6

SPAT1260

SPAT

Consultation of another employee

1.7

12.6

258

1634

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

12.6

439

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.3

12.5

151

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

17.5

12.5

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.0

12.5

183

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

12.5

297

1958

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

131.2

12.5

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.7

12.4

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

4.2

12.3

WX202

NOMESCO Finland

Supraclavicular plexus blockade

4.2

12.3

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

3.7

12.3

104

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

12.2

126

640

R02

ICPC

Shortness of breath/dyspnoea

1.8

12.2

195

1148

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

12.2

241

A04

ICPC

Weakness/tiredness general

1.8

12.2

219

1335

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

12.2

202

1203

C07AB07

ATC

bisoprolol; oral

1.5

12.2

671

5341

SAA04

NOMESCO Finland

Special examination of mouth

2.4

12.2

362

ZYC01

NOMESCO Finland

Remote contact by phone

2.4

12.1

388

T71

ICPC

Malignant neoplasm thyroid

27.0

12.1

ZXA00

NOMESCO Finland

Right side

1.6

12.0

384

2716

D68.8

ICD-10 Finland

Other specified coagulation defects

5.1

12.0

SPAT1234

SPAT

Support of social functional capacity

2.3

12.0

403

J96.1

ICD-10 Finland

Chronic respiratory failure

3.7

11.9

106

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

11.9

412

2965

NC2AA

NOMESCO Finland

Forearm X-ray examination

4.1

11.9

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

47.1

11.9

XF600

NOMESCO Finland

Bloodpressure measurement

2.3

11.9

430

ZXE00

NOMESCO Finland

One hour or less

1.5

11.8

518

3923

L04AD02

ATC

tacrolimus; systemic

11.8

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

11.8

104

497

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

11.8

176

1015

J02AC01

ATC

fluconazole; systemic

1.5

11.8

562

4333

R03DC01

ATC

zafirlukast; oral

3.8

11.8

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.0

11.8

173

NDG76

NOMESCO Finland

Fusion of DIP joint

5.2

11.8

UKC02

NOMESCO Finland

Cystoscopy

1.8

11.7

189

1116

N03AX09

ATC

lamotrigine; oral

2.6

11.7

264

9284

FHL

Wrist ossification surgery

30.3

11.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

11.6

401

2881

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

11.6

501

3778

SPAT1210

SPAT

Application of cast or individual aid

2.5

11.6

307

T99

ICPC

Endocr/metab/nutrit disease other

4.0

11.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

11.6

118

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

11.6

163

923

M48.5

ICD-10 Finland

Collapsed vertebra, not elsewhere classified

11.2

11.5

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

10.1

11.5

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

11.5

920

7868

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.6

11.5

109

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

13.7

11.5

N06AA09

ATC

amitriptyline; systemic

1.9

11.5

160

903

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

11.5

199

1201

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

4.6

11.4

E22.1

ICD-10 Finland

Hyperprolactinaemia

121.0

11.4

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.8

11.4

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.0

11.4

176

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

11.4

316

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

11.4

102

491

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

5.4

11.4

K07.60

ICD-10 Finland

Snapping jaw

2.4

11.4

348

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

3.0

11.3

166

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

15.2

11.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

11.3

400

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

11.3

145

796

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

35.3

11.3

S72.1

ICD-10 Finland

Pertrochanteric fracture

3.1

11.2

151

RS222, ,

NOMESCO Finland

4.5

11.2

R4120

NOMESCO Finland

Occupational therapy

2.2

11.2

474

UJF92

NOMESCO Finland

Capsular endoscopy

3.6

11.2

106

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

11.2

667

5363

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

12.8

11.1

M79.6

ICD-10 Finland

Pain in limb

1.5

11.1

577

4509

3AC01, ,

NOMESCO Finland

5.3

11.1

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.6

11.0

254

S72.4

ICD-10 Finland

Fracture of lower end of femur

5.1

11.0

H26.4

ICD-10 Finland

After-cataract

1.8

11.0

171

998

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

11.0

117

602

Z31.5

ICD-10 Finland

Genetic counselling

2.4

11.0

322

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

11.0

341

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

11.0

412

N06AX11

ATC

mirtazapine; oral

1.5

10.9

463

3469

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

10.9

267

1766

TGC00

NOMESCO Finland

Bronchial lavation

3.2

10.9

133

SFA30

NOMESCO Finland

Three-surface restoration

1.5

10.9

528

4068

A02BC01

ATC

omeprazole; systemic

1.5

10.8

374

2681

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

4.0

10.8

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

10.7

10.8

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.5

10.8

104

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

10.8

435

L01BB01, ,

ATC

28.3

10.7

N02BF01

ATC

gabapentin; oral

2.0

10.7

128

687

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

10.6

191

1163

G47.3

ICD-10 Finland

Sleep apnoea

1.6

10.6

257

1696

L02

ICPC

Back symptom/complaint

1.9

10.6

143

799

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

5.1

10.5

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.6

10.5

258

1706

R4190

NOMESCO Finland

Nutritional therapy

2.8

10.5

196

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

10.5

231

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

3.3

10.5

121

E27.2

ICD-10 Finland

Addisonian crisis

+∞

10.4

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

+∞

10.4

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

+∞

10.4

25298

ICD-8 Finland

Diseases of parathyroid gland, Alii definiti

+∞

10.4

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.1

10.4

142

WZA00

NOMESCO Finland

Concise certificate

2.1

10.4

461

N04BC05

ATC

pramipexole; oral

2.0

10.4

123

657

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

10.4

109

558

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.4

10.3

107

N02AC04

ATC

dextropropoxyphene; oral

2.6

10.3

239

-50

ICPC

Medication/prescr/renewal

2.5

10.3

257

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

10.3

121

645

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.8

10.3

RS221, ,

NOMESCO Finland

4.1

10.3

C08CA05

ATC

nifedipine; systemic

2.2

10.2

417

K02.1

ICD-10 Finland

Caries of dentine

1.5

10.2

721

5947

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.8

10.2

156

906

H25.8

ICD-10 Finland

Other senile cataract

1.8

10.2

173

1037

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.3

10.1

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.4

10.1

290

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

10.1

363

2620

K08.3

ICD-10 Finland

Retained dental root

2.0

10.1

106

543

M01AH02

ATC

rofecoxib; oral

1.7

10.1

194

1204

E87.5

ICD-10 Finland

Hyperkalaemia

3.5

10.1

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

10.0

454

W10

ICD-10 Finland

Fall on and from stairs and steps

2.2

10.0

375

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.1

10.0

442

N05BA01

ATC

diazepam; systemic, rectal

1.7

9.9

185

1137

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.5

9.9

SPAT1312

SPAT

General health counselling

1.5

9.9

413

3072

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

9.9

281

N18.0

ICD-10 Finland

End-stage renal disease

8.2

9.8

H05BX01

ATC

cinacalcet; oral

26.2

9.8

ZX108

NOMESCO Finland

Inhalation

9.6

9.8

ZY010

NOMESCO Finland

Hospital outpatient

2.4

9.8

301

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

9.7

379

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.1

9.7

R03DC03

ATC

montelukast; oral

1.6

9.7

225

1465

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

3.9

9.7

E000002, ,

ATC

1.8

9.7

142

813

A01AB10

ATC

natamycin; local oral

2.7

9.7

193

M84.1

ICD-10 Finland

Nonunion of fracture [pseudarthrosis]

5.3

9.6

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

9.6

126

696

P01AB01

ATC

metronidazole; oral, rectal

1.4

9.6

546

4308

C10AC01

ATC

colestyramine; oral

2.9

9.5

155

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

9.5

503

3912

A10AC01

ATC

insulin (human); parenteral

2.0

9.5

102

526

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

15.1

9.5

SCA02

NOMESCO Finland

Preventive oral health care

1.8

9.5

136

773

UJD02

NOMESCO Finland

Gastroscopy

2.3

9.5

337

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.7

9.5

201

R06AE07

ATC

cetirizine; oral

1.4

9.5

587

4703

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

9.5

357

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.5

9.5

237

M01AH01

ATC

celecoxib; oral

1.6

9.5

256

1731

S76

ICPC

Skin infection other

2.2

9.4

364

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.6

9.4

202

2581B

ICD-9 Finland

Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]

+∞

9.4

78892

ICD-8 Finland

Other general symptoms, Hypocalcaemia

+∞

9.4

H01AC01

ATC

somatropin; parenteral

+∞

9.4

XKD00

NOMESCO Finland

Uroflowmetry

1.9

9.4

130

732

J01DA01

ATC

[U] cefalexin

1.4

9.3

809

6879

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

9.3

257

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

3.1

9.3

130

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.5

9.3

ZZH40

NOMESCO Finland

Substitute of bone

4.5

9.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.7

9.3

OAB50, ,

SPAT

2.2

9.3

380

R03BA05

ATC

fluticasone; inhalant

1.6

9.3

245

1647

A01AB04

ATC

amphotericin B; local oral

2.2

9.2

387

S82.1

ICD-10 Finland

Fracture of upper end of tibia

3.2

9.2

110

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

9.2

686

5671

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

9.2

332

2391

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.3

9.2

105

24210

ICD-8 Finland

Thyrotoxicosis with or without goitre, Toxic nodular goitre

13.8

9.2

WX402

NOMESCO Finland

General anaesthesia

1.6

9.1

262

1795

T84.1

ICD-10 Finland

Mechanical complication of internal fixation device of bones of limb

5.1

9.1

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.8

9.1

D68.9

ICD-10 Finland

Coagulation defect, unspecified

11.5

9.1

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

3.4

9.1

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.8

9.0

160

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

36.9

9.0

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

36.9

9.0

R4130

NOMESCO Finland

Speech therapy

3.0

9.0

138

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.7

9.0

183

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

4.1

9.0

R52.9

ICD-10 Finland

Pain, unspecified

1.8

9.0

135

779

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

9.0

495

3872

ZXA05

NOMESCO Finland

Left side

1.5

9.0

345

2517

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.2

9.0

112

Z94.4

ICD-10 Finland

Liver transplant status

18.7

8.9

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.8

8.9

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.5

8.9

226

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.5

8.9

220

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

4.9

8.8

I50.0

ICD-10 Finland

Congestive heart failure

2.0

8.8

101

533

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

3.5

8.8

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

8.8

235

1582

107

Kela drug reimbursment

Pernicious anaemia

3.3

8.8

103

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

10.8

8.8

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

10.8

8.8

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

8.8

245

1666

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.3

8.8

290

J01FA06

ATC

roxithromycin; oral

1.4

8.7

533

4240

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

8.7

175

1097

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

14.1

8.7

NAK40

NOMESCO Finland

Vertebroplasty

50.3

8.7

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

4.3

8.7

K62.3

ICD-10 Finland

Rectal prolapse

3.5

8.7

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

6.6

8.7

E86

ICD-10 Finland

Volume depletion

2.9

8.6

136

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

8.6

244

1664

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

8.6

292

M35.3

ICD-10 Finland

Polymyalgia rheumatica

2.2

8.6

338

J01DA06

ATC

[U] cefuroxime

1.6

8.6

191

1229

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

8.6

298

2126

WX212

NOMESCO Finland

Femoral plexus blockade

2.8

8.6

159

R03AC03

ATC

terbutaline; inhalant

1.6

8.6

190

1222

M40.1

ICD-10 Finland

Other secondary kyphosis

16.4

8.6

9289

FHL

Other measure in this category

16.4

8.6

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

16.4

8.6

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.6

8.5

194

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

8.5

122

693

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.6

8.5

J47

ICD-10 Finland

Bronchiectasis

3.0

8.5

126

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

8.5

504

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.4

8.5

249

Z01.2

ICD-10 Finland

Dental examination

1.4

8.5

567

4574

L86

ICPC

Back syndrome with radiating pain

2.0

8.5

448

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.3

8.5

100

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

6.4

8.5

321

Kela drug reimbursment

Paricalcitol and cinacalcet

27.7

8.5

WX730

NOMESCO Finland

Conventional respirator

4.2

8.5

L29

ICPC

Musculoskeletal sympt/complt other

1.8

8.4

124

711

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.7

8.4

172

M05BX06

ATC

romosozumab; parenteral

90.6

8.4

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

90.6

8.4

JN6AD

NOMESCO Finland

CT of torso and neck

3.5

8.4

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

8.4

378

2840

NF3AD

NOMESCO Finland

Femur CT

12.8

8.4

NA2AD

NOMESCO Finland

Thoracic spine CT examination

6.7

8.4

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

4.0

8.4

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

4.0

8.4

H26.02

ICD-10 Finland

Presenil cataract

2.8

8.3

150

J20

ICD-10 Finland

Acute bronchitis

1.8

8.3

141

843

R06.4

ICD-10 Finland

Hyperventilation

3.7

8.3

D07AC01

ATC

betamethasone; topical

1.4

8.3

453

3525

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.1

8.3

107

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.7

8.3

162

R03AC12

ATC

salmeterol; inhalant

2.2

8.3

317

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.2

8.3

304

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.5

8.2

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

14.6

8.2

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

14.6

8.2

NDC40

NOMESCO Finland

Secondary prosthetic replacement in of joint of finger or metacarpal

14.6

8.2

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

6.5

8.2

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.6

8.1

175

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.6

8.1

SPAT1172

SPAT

Guidance concerning hydration

2.8

8.1

152

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

8.1

305

2209

N05BA04

ATC

oxazepam; oral

1.5

8.1

348

2588

Z49.0

ICD-10 Finland

Preparatory care for dialysis

8.2

8.1

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

8.2

8.1

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

33.6

8.1

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.8

8.1

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

17.3

8.1

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

8.0

328

2414

C08CA02

ATC

felodipine; oral

1.8

8.0

129

759

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

8.0

475

3744

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

8.0

108

602

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

8.0

263

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.8

8.0

110

618

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

8.0

438

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

7.3

8.0

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

8.0

195

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

8.0

233

1600

J01FA01

ATC

erythromycin; systemic

1.7

7.9

167

1059

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

4.5

7.9

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.6

7.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.9

7.9

483

A29

ICPC

General symptom/complaint other

1.6

7.8

171

1095

J01AA02

ATC

doxycycline; systemic

1.4

7.8

1023

9206

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

7.8

292

2111

B07.9

ICD-10 Finland

Verruca simplex

2.5

7.8

191

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

9.5

7.8

R03BA08

ATC

ciclesonide; inhalant

1.8

7.8

118

683

D07AB08

ATC

desonide; topical

1.7

7.8

142

867

H02AB08

ATC

triamcinolone; systemic

7.0

7.8

R01AD09

ATC

mometasone; nasal

1.4

7.8

571

4664

M03BX02

ATC

tizanidine; oral

1.4

7.8

781

6714

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

7.7

305

2228

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

7.7

326

SFA10

NOMESCO Finland

One-surface restoration

1.4

7.7

671

5630

A03FA02

ATC

cisapride; oral, rectal

1.8

7.7

111

632

NDG77

NOMESCO Finland

Other excision, reconstruction or fusion of joint of first finger

15.1

7.7

3079, ,

Kela drug reimbursment

45.2

7.7

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

7.7

148

916

Z71.8

ICD-10 Finland

Other specified counselling

1.4

7.7

390

2988

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.9

7.7

480

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.8

7.6

E000006, ,

ATC

1.9

7.6

101

561

M05BA08

ATC

zoledronic acid; parenteral

18.5

7.6

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

18.5

7.6

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.3

7.6

256

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

8.1

7.6

A06AC51

ATC

ispaghula, combinations; oral

2.1

7.6

376

N02BF02

ATC

pregabalin; oral

2.0

7.6

432

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.9

7.6

JJC00

NOMESCO Finland

Allogenic transplantation of liver

25.2

7.6

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

3.8

7.5

XF402

NOMESCO Finland

ECG with work load test

1.7

7.5

140

859

K92.0

ICD-10 Finland

Haematemesis

3.0

7.5

108

L14

ICPC

Leg/thigh symptom/complaint

1.8

7.5

119

698

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.8

7.5

125

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.9

7.4

L13

ICPC

Hip symptom/complaint

1.5

7.4

275

1982

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.6

7.4

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

3.6

7.4

S92.5

ICD-10 Finland

Fracture of other toe

2.7

7.4

148

T89

ICPC

Diabetes insulin dependent

2.4

7.4

208

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

80.5

7.4

WX892

NOMESCO Finland

Monitored bed care

1.9

7.4

522

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

7.4

133

809

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

13.4

7.4

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

7.4

816

7096

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.2

7.4

266

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.8

7.4

126

M43.1

ICD-10 Finland

Spondylolisthesis

2.1

7.3

306

L04AA24

ATC

abatacept; parenteral

8.4

7.3

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

8.4

7.3

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.8

7.3

132

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

7.3

103

583

B82

ICPC

Anaemia other/unspecified

2.6

7.3

167

BAA25

NOMESCO Finland

Bilateral partial excision of thyroid gland

10.9

7.3

25810

ICD-8 Finland

Polyglandular dysfunction and other diseases of endocrine glands, Polyglandular dysfunction

+∞

7.3

E31.0

ICD-10 Finland

Autoimmune polyglandular failure

+∞

7.3

BBA99

NOMESCO Finland

Other operations on parathyroid gland

+∞

7.3

A12AA03

ATC

calcium gluconate; oral

+∞

7.3

25200

ICD-8 Finland

Diseases of parathyroid gland, Hyperparathyroidism

+∞

7.3

SPAT1252

SPAT

Overall medication plan or its review

1.9

7.3

532

S72.0

ICD-10 Finland

Fracture of neck of femur

2.1

7.3

307

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

4.2

7.3

R4110

NOMESCO Finland

Physiotherapy

1.4

7.3

361

2750

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

7.3

150

946

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

3.3

7.3

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.6

7.2

162

1043

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.8

7.2

113

660

8330/3-C73.9

ICD-O-3

Follicular carcinoma, NOS, of thyroid gland

15.8

7.2

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

4.3

7.2

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.3

7.2

GBB00

NOMESCO Finland

Tracheostomy

4.3

7.2

R42

ICD-10 Finland

Dizziness and giddiness

1.5

7.2

308

2282

V03AE01

ATC

polystyrene sulfonate; oral

4.5

7.2

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.0

7.2

M81.1

ICD-10 Finland

Postoophorectomy osteoporosis

30.2

7.2

H01CB03

ATC

lanreotide; parenteral

30.2

7.2

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

30.2

7.2

D44.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Endocrine gland, unspecified

30.2

7.2

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.5

7.1

187

H65.3

ICD-10 Finland

Chronic mucoid otitis media

3.2

7.1

ZXD00

NOMESCO Finland

Emergency procedure

2.6

7.1

163

WX213

NOMESCO Finland

Lower leg blockade

8.0

7.1

Z00.0

ICD-10 Finland

General medical examination

1.5

7.1

240

1697

J01EA01

ATC

trimethoprim; systemic

1.4

7.1

389

3014

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

4.1

7.1

UDC00

NOMESCO Finland

Ear microscopy

1.8

7.1

537

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

7.1

443

C07AA05

ATC

propranolol; systemic

1.5

7.0

257

1846

J01FA10

ATC

azithromycin; systemic

1.4

7.0

722

6184

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.8

7.0

118

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

7.0

265

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

7.0

101

576

EB1WA, ,

NOMESCO Finland

7.0

49300

ICD-8 Finland

Asthma, bronchiale

2.8

7.0

124

H20.1

ICD-10 Finland

Chronic iridocyclitis

3.9

7.0

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

7.0

374

NG1AD

NOMESCO Finland

Knee CT examination

3.0

7.0

102

N19

ICD-10 Finland

Unspecified kidney failure

2.3

7.0

214

S19

ICPC

Skin injury other

2.2

7.0

259

L16

ICPC

Ankle symptom/complaint

1.6

7.0

151

964

R03BA02

ATC

budesonide; inhalant

1.5

7.0

232

1635

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.4

7.0

R06.2

ICD-10 Finland

Wheezing

2.2

7.0

266

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.0

6.9

396

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

6.9

145

918

NG1DA

NOMESCO Finland

X-ray of knees

2.8

6.9

119

121

Kela drug reimbursment

Severe hypofunction of sexual glands

2.8

6.9

119

R5120

NOMESCO Finland

Preparation of an aid

2.4

6.9

196

Z49.1

ICD-10 Finland

Extracorporeal dialysis

5.5

6.9

NE1BA

NOMESCO Finland

Pelvis extensive X-ray examination

3.1

6.9

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

2.2

6.9

267

A10AB01

ATC

insulin (human); parenteral

2.5

6.9

178

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

13.8

6.9

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

6.9

211

1461

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.3

6.8

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

6.8

398

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

6.8

113

671

137

Kela drug reimbursment

Uraemia requiring dialysis

8.3

6.8

9522

FHL

Synovectomy

8.3

6.8

G72.9

ICD-10 Finland

Myopathy, unspecified

4.1

6.8

S01XA18

ATC

ciclosporin; ophthalmic

4.1

6.8

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

3.8

6.8

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.8

6.8

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.4

6.8

198

NHG20

NOMESCO Finland

Fusion of talocrural joint

6.1

6.8

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

6.8

113

673

P01BA01

ATC

chloroquine; systemic

5.7

6.8

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.7

6.8

E26.0

ICD-10 Finland

Primary hyperaldosteronism

40.3

6.8

V03AE03

ATC

lanthanum carbonate; oral

40.3

6.8

E03

ICD-10 Finland

Other hypothyroidism

1.8

6.8

523

M02AA10

ATC

ketoprofen; topical

1.5

6.8

209

1450

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

6.7

338

2575

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.0

6.7

358

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

6.7

103

598

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.5

6.7

168

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

6.7

162

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.9

6.7

A07EA06

ATC

budesonide; oral, local oral

2.3

6.7

218

J94.8

ICD-10 Finland

Other specified pleural conditions

3.4

6.7

R35

ICD-10 Finland

Polyuria

1.9

6.7

423

9256

FHL

Synovectomy (knee 9311)

22.6

6.7

C739, ,

ICD-10 Finland

22.6

6.7

347

Kela drug reimbursment

denosumab

22.6

6.7

R05

ICD-10 Finland

Cough

1.5

6.7

276

2031

B80

ICPC

Iron deficiency anaemia

2.6

6.6

145

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.5

6.6

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.1

6.6

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

6.6

310

2332

E000001, ,

ATC

1.5

6.6

246

1772

NBB10

NOMESCO Finland

Primary partial prosthetic replacement of humero-scapular joint not using cement, other or unspecified

5.5

6.6

B03XA01

ATC

erythropoietin; parenteral

5.5

6.6

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.6

6.6

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.2

6.6

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.7

6.6

134

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

12.3

6.6

N06AX16

ATC

venlafaxine; oral

1.6

6.6

174

1166

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.4

6.6

176

R03BA01

ATC

beclometasone; inhalant

1.6

6.6

181

1224

M70.2

ICD-10 Finland

Olecranon bursitis

2.6

6.6

146

WVA30, ,

SPAT

2.0

6.6

327

R03AK11

ATC

formoterol and fluticasone; inhalant

2.5

6.6

152

WX872

NOMESCO Finland

Intensive care

2.1

6.6

293

ZY000

NOMESCO Finland

Hospital inpatient

3.8

6.5

ZX112

NOMESCO Finland

Subcutaneous

2.6

6.5

135

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.6

6.5

147

J01XX08

ATC

linezolid; systemic

6.2

6.5

NHG24

NOMESCO Finland

Fusion of subtalar joint and between bones of ankle

5.4

6.5

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

5.4

6.5

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.2

6.5

J01FA09

ATC

clarithromycin; systemic

1.4

6.5

379

2964

K92.1

ICD-10 Finland

Melaena

2.0

6.4

357

A08

ICPC

Swelling

1.9

6.4

443

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

6.4

443

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

70.2

6.4

BCA30

NOMESCO Finland

Unilateral adrenalectomy

70.2

6.4

S22

ICPC

Nail symptom/complaint

1.8

6.4

480

TQW99

NOMESCO Finland

Other minor procedure on skin

1.9

6.4

379

9527

FHL

Alloarthroplasty, implant or endoprosthesis

14.4

6.4

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

14.4

6.4

J05AB11

ATC

valaciclovir; oral

1.5

6.4

191

1315

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

6.4

262

1923

R52.1

ICD-10 Finland

Chronic intractable pain

3.8

6.4

A02BC03

ATC

lansoprazole; oral

1.4

6.4

378

2961

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

6.3

388

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

2.1

6.3

277

L74

ICPC

Fracture: hand/foot bone

2.6

6.3

143

1XC02, ,

NOMESCO Finland

5.5

6.3

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.5

6.3

NDG79

NOMESCO Finland

Other excision, reconstruction or fusion of joint of II-V finger

11.1

6.3

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

9.3

6.3

E04.8

ICD-10 Finland

Other specified nontoxic goitre

9.3

6.3

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

6.3

271

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

3.9

6.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

6.3

549

4565

E28.3

ICD-10 Finland

Primary ovarian failure

18.1

6.3

H28.1*E20.9

ICD-10 Finland

Cataract in hypoparathyroidism

+∞

6.3

M08.8

ICD-10 Finland

Other juvenile arthritis

+∞

6.3

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

+∞

6.3

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.2

6.2

225

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

3.0

6.2

Y96.9

ICD-10 Finland

Unspecified type of accident

2.8

6.2

109

D09AB01

ATC

zinc bandage without supplements; topical

2.8

6.2

109

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

6.2

162

WX1PA

NOMESCO Finland

Total body mineral density measurement with Dual energy X-ray absorptiometry (DXA)

26.8

6.2

M80.1

ICD-10 Finland

Postoophorectomy osteoporosis with pathological fracture

26.8

6.2

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

26.8

6.2

R03BB01

ATC

ipratropium bromide; inhalant

2.2

6.2

245

M01AX17

ATC

nimesulide; oral

1.4

6.2

323

2472

I50

ICD-10 Finland

Heart failure

2.3

6.2

200

R81

ICPC

Pneumonia

2.2

6.2

213

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

2.2

6.2

213

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

6.2

561

4686

N30.0

ICD-10 Finland

Acute cystitis

1.5

6.2

235

1699

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.2

6.2

M01AE51

ATC

ibuprofen, combinations; systemic

3.2

6.2

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.5

6.2

Angiography of the heart and coronary arteries

1.9

6.2

370

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.6

6.2

127

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.4

6.2

SPAT1097

SPAT

Recording of ECG

1.5

6.1

194

1351

NF3BA

NOMESCO Finland

Femur extensive X-ray examination

7.7

6.1

J01CA04

ATC

amoxicillin; systemic

1.4

6.1

1042

9544

M01AE02

ATC

naproxen; oral, rectal

1.3

6.1

707

6113

S70.0

ICD-10 Finland

Contusion of hip

2.1

6.1

274

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

6.1

259

1913

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.9

6.1

SPAT1291

SPAT

Other function in accordance with NCSP classification

2.9

6.1

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

6.1

228

ZX121

NOMESCO Finland

Central venous catheter

8.6

6.1

L01CB

ATC

Podophyllotoxin derivatives

8.6

6.1

L04AA29

ATC

[U] tofacitinib

8.6

6.1

A10AE05

ATC

insulin detemir; parenteral

2.0

6.1

337

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.0

303

2304

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

6.7

6.0

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

6.1

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

564

873

10.32

307.65

4.9

2.8

56.03

76.82

ng/l

5.82

457

741

(3003458) Phosphate [Moles/volume] in Serum or Plasma

664

1370

8.51

307.65

6.9

4.5

1.15

1.06

mmol/l

11.81

623

1256

(3010838) Calcium [Moles/time] in 24 hour Urine

311

145

27.50

307.65

3.2

1.7

4.60

4.47

mmol/24h

0.18

279

128

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1102

5096

7.11

211.02

5.2

2.2

85.26

79.35

nmol/l

10.84

1028

4507

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

142

24.27

195.29

6.5

6.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1174

5967

8.04

194.97

19.3

5.8

1.18

1.22

mmol/l

30.57

964

5057

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

88.89

187.96

2.1

1.7

0.31

0.21

ug/l

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1095

5447

6.17

179.73

16.4

5.1

1.18

1.21

mmol/l

31.27

1032

4910

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

178

172

11.76

164.67

2.9

2.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

146

104

15.61

162.64

6.0

4.9

86.85

53.08

u/ml

0.21

(3018418) pH of Serum or Plasma

824

3583

4.29

152.60

12.9

3.4

7.40

0.13

254

645

(3012095) Magnesium [Moles/volume] in Serum or Plasma

540

1816

4.27

141.57

5.4

3.1

0.79

0.81

mmol/l

5.57

507

1694

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

312

719

5.33

131.29

5.2

3.2

4.32

4.50

pmol/l

2.17

282

625

(3036481) Cortisol [Moles/volume] in Serum or Plasma

376

1030

4.66

128.01

2.5

1.9

311.04

385.98

nmol/l

4.72

348

929

(3015377) Calcium [Moles/volume] in Serum or Plasma

852

4208

3.74

121.69

4.6

3.3

2.26

2.36

mmol/l

39.67

749

3661

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

49.92

106.72

2.3

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

284

802

4.21

90.47

2.2

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

309

952

3.91

86.91

2.3

2.8

65.52

66.50

g/l

1.39

271

858

(3012565) Volume of 24 hour Urine

19.14

80.74

3.2

2.2

1971.19

1852.00

0.25

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

297

970

3.64

75.85

11.6

3.2

1.19

1.23

mmol/l

15.06

286

823

(40760892) CBC W Ordered Manual Differential panel - Blood

876

5358

2.78

70.21

12.3

6.0

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

845

5152

2.69

66.82

7.3

4.2

34.34

35.43

g/l

6.71

796

4773

(3006315) Basophils [#/volume] in Blood

902

5709

2.72

65.60

11.3

5.5

0.04

e9/l

0.66

832

4876

(3001604) Monocytes [#/volume] in Blood

899

5704

2.70

64.65

11.3

5.5

0.60

0.57

e9/l

2.96

830

4870

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

157

362

4.77

64.00

2.3

3.6

1.02

1.71

ratio

0.70

(3013115) Eosinophils [#/volume] in Blood

919

5918

2.70

63.70

11.7

5.8

0.18

e9/l

0.03

843

5131

(3034860) Kappa light chains.free [Mass/volume] in Serum

159

372

4.71

63.66

2.5

3.6

33.19

60.59

mg/l

1.00

109

315

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

158

374

4.65

62.32

2.6

3.6

25.68

60.40

mg/l

1.41

109

317

(3019198) Lymphocytes [#/volume] in Blood

906

5855

2.64

61.27

11.4

5.6

1.74

1.88

e9/l

2.75

846

5124

(3005719) IgG [Mass/volume] in Serum or Plasma

242

810

3.42

58.47

4.5

2.8

9.46

10.36

g/l

2.20

225

734

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1196

9037

3.67

58.38

14.8

7.2

77.81

79.01

u/l

0.26

1160

8451

(40760888) Immunoglobulin light chains.free panel - Serum

126

268

5.08

56.39

2.7

4.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

558

2964

2.50

56.24

3.1

2.2

3.71

3.07

mg/l

4.14

478

2507

(3022096) Basophils/100 leukocytes in Blood

820

5202

2.45

55.32

11.8

5.7

0.70

0.68

0.28

768

4810

(3006504) Eosinophils/100 leukocytes in Blood

836

5358

2.45

54.99

11.6

5.7

2.73

2.77

0.21

785

4966

(3019069) Monocytes/100 leukocytes in Blood

837

5382

2.44

54.42

12.3

6.0

8.54

8.53

0.01

786

4996

(3002030) Lymphocytes/100 leukocytes in Blood

844

5513

2.40

51.95

11.9

5.8

25.16

27.88

11.17

794

5130

(3013650) Neutrophils [#/volume] in Blood by Automated count

970

6759

2.51

51.33

14.4

8.8

4.58

4.06

e9/l

7.17

890

5854

(3028026) IgM [Mass/volume] in Serum or Plasma

201

647

3.47

51.30

2.8

1.8

1.14

1.38

g/l

1.39

181

583

(3022217) INR in Platelet poor plasma by Coagulation assay

827

5386

2.36

50.78

20.1

14.9

1.25

inr

0.05

280

1493

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

7.62

49.94

1.4

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

830

5438

2.35

49.90

11.2

5.6

60.15

57.27

9.89

781

5052

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

337

1509

2.64

47.46

3.4

2.2

18.85

22.06

4.23

288

1284

(3022948) Iron [Moles/volume] in Serum or Plasma

376

1778

2.54

47.26

3.4

2.2

10.82

12.68

umol/l

6.13

346

1654

(3004789) Transferrin [Mass/volume] in Serum or Plasma

348

1616

2.55

45.21

3.3

2.2

2.31

2.35

g/l

0.64

322

1494

(3019309) Folate [Moles/volume] in Red Blood Cells

445

2317

2.37

44.89

1.9

1.7

1259.46

1193.86

nmol/l

0.60

342

1694

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

480

2611

2.30

43.45

1.4

1.3

0.84

1.69

u/ml

2.06

148

654

(3023368) Bacteria identified in Blood by Culture

534

3061

2.23

42.33

6.5

4.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

293

1295

2.61

41.85

2.9

2.5

1.89

1.84

0.30

260

1142

(3013826) Glucose [Moles/volume] in Serum or Plasma

935

6710

2.26

41.52

7.2

4.3

6.53

6.71

mmol/l

2.08

905

6286

(3020779) Urea [Moles/volume] in Serum or Plasma

228

897

2.85

40.83

10.8

5.8

10.46

9.27

mmol/l

1.08

220

851

(3019225) pH of Specimen

276

1198

2.64

40.82

12.2

3.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

422

2230

2.29

40.42

2.2

1.5

2.28

2.34

g/l

0.25

278

1269

(3012501) Base excess in Blood by calculation

224

4.59

39.13

4.9

3.7

3.15

2.89

mmol/l

0.31

157

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

279

1242

2.57

39.03

4.8

4.3

250.81

252.33

u/l

0.06

252

1163

(3023520) Reticulocytes [#/volume] in Blood

236

967

2.74

39.01

3.4

2.5

73.05

71.10

e9/l

0.34

187

733

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

180

644

3.07

38.13

5.2

3.8

2.69

1.87

mmol/l

1.98

149

480

(3007853) Bacteria identified in Skin by Aerobe culture

280

1262

2.53

38.09

2.7

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

217

863

2.80

37.92

5.5

3.6

0.72

0.68

0.14

252

(3017181) Myelocytes/100 leukocytes in Blood

230

943

2.73

37.90

5.6

3.8

1.01

1.03

0.04

300

(3044927) Protein electrophoresis panel - Urine

125

5.85

37.81

1.2

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

186

683

3.00

37.62

5.4

3.8

5.35

5.18

kpa

1.72

179

653

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1151

9197

2.63

37.39

8.6

4.2

16.44

14.89

pmol/l

52.29

1060

8305

(3042936) Bacteria identified in Isolate by Culture

326

1595

2.37

36.92

3.3

1.9

—

(3009343) pH of Capillary blood

183

674

2.98

36.78

5.3

3.8

7.43

7.41

1.44

(3009445) Proteinase 3 Ab [Units/volume] in Serum

144

462

3.37

36.53

2.0

1.4

15.46

11.70

u/ml

—

(1616796) Gas panel - Central venous blood

220

4.46

36.37

3.9

3.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

220

902

2.72

36.15

5.7

3.8

0.11

0.13

0.15

255

(3025159) Blasts/100 leukocytes in Blood

211

849

2.76

35.95

5.7

3.9

0.09

0.47

0.42

203

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

577

3609

2.04

34.65

2.6

2.1

144.73

209.48

u/l

1.78

535

3372

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

207

842

2.72

34.46

2.3

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

148

502

3.19

34.22

2.4

1.7

1.52

g/l

0.00

126

435

(3013707) Erythrocyte sedimentation rate by Westergren method

1095

8692

2.33

33.70

9.0

4.2

16.24

13.12

mm/h

8.31

1022

7989

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

362

1916

2.21

33.62

2.3

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

718

4920

1.97

32.58

4.1

2.7

127.91

110.76

ug/l

0.56

647

4494

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

418

2368

2.10

32.43

4.5

2.9

2.39

2.46

mmol/l

9.67

366

2083

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

117

356

3.50

32.17

1.8

1.6

656.00

116.67

titre

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

842

6136

1.98

31.43

8.4

5.9

10.49

11.07

umol/l

0.52

801

5801

(3035637) Corticotropin [Mass/volume] in Plasma

107

5.72

31.33

1.6

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

468

3.14

31.23

1.7

2.3

7.49

7.57

g/l

0.18

116

423

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

137

468

3.14

31.23

1.7

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

136

467

3.12

30.72

1.7

2.3

3.61

3.63

g/l

0.08

116

423

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

440

3.19

30.72

1.7

2.4

2.91

3.07

g/l

1.02

111

395

(3000850) Epithelial cells [#/volume] in Urine

421

2436

2.05

30.54

3.7

2.5

5.21

7.02

e6/l

2.38

383

2177

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

6.56

30.02

1.8

1.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

173

4.47

29.34

1.5

1.3

12.41

12.18

u/l

0.04

133

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.97

28.98

2.4

1.3

6.41

7.31

g/l

0.62

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.97

28.98

2.4

1.3

0.38

0.37

g/l

0.05

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.97

28.98

2.4

1.3

2.58

2.67

g/l

0.11

(3037522) Nuclear Ab [Titer] in Serum

293

1509

2.20

28.60

1.6

1.3

513.68

586.94

titre

0.29

340

(4062490) Immunoglobulin typing, IgG

5.84

28.33

2.6

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

146

4.70

28.01

2.3

1.7

0.62

0.83

g/l

0.55

111

(3026782) Osmolality of Urine

400

2333

2.01

27.98

4.4

2.8

481.33

522.09

mosm/kgh2o

3.66

349

1991

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

443

3.06

27.87

1.6

2.4

9.45

10.19

g/l

1.00

106

395

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

107

340

3.33

27.43

2.7

1.6

0.23

g/l

0.14

323

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

120

409

3.12

27.40

2.1

2.5

0.33

1.00

g/l

1.65

357

(3037121) Protein [Mass/volume] in Urine

118

399

3.14

27.31

2.5

3.0

0.40

0.30

g/l

0.24

141

(3037756) Immunofixation for Serum or Plasma

261

3.66

27.30

1.6

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

229

3.84

27.12

4.4

3.2

61.98

58.17

1.81

229

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

243

1183

2.28

27.08

4.9

3.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

753

5460

1.85

26.60

3.5

2.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

276

3.54

26.51

3.9

4.0

1.73

1.48

mg/l

1.42

251

(40767503) Oxygen content in Capillary blood by calculation

215

3.89

26.35

3.2

2.3

15.73

15.87

0.10

108

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

229

1105

2.29

25.99

3.1

2.0

0.20

0.21

g/l

0.90

215

1035

(3021589) Normoblasts [#/volume] in Blood

711

5096

1.83

25.77

20.0

9.2

0.00

e9/l

0.62

637

4127

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

121

433

2.97

25.35

2.4

2.0

2.66

1.87

ug/l

0.33

103

378

(3030905) Polymorphonuclear cells [#/volume] in Blood

221

3.78

25.34

4.3

3.0

4.41

4.23

e9/l

0.29

221

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

106

353

3.17

25.14

2.6

1.6

1.18

1.20

g/l

0.15

335

(3023419) Bacteria identified in Sputum by Culture

164

4.25

25.04

3.1

2.7

—

(3044640) Blood type and Crossmatch panel - Blood

555

3720

1.83

24.79

3.5

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

541

3604

1.83

24.60

3.6

3.0

6.30

6.71

mmol/l

1.48

476

3006

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

122

448

2.89

24.39

2.3

2.0

38.77

40.21

u/l

0.28

102

390

(3022313) Gas panel - Capillary blood

131

502

2.78

24.18

5.6

3.8

—

(3027801) Oxygen [Partial pressure] in Arterial blood

247

1264

2.17

24.15

7.4

6.3

11.72

12.34

kpa

1.13

236

1208

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

247

1264

2.17

24.15

7.4

6.3

5.12

5.09

kpa

0.22

237

1208

(3016502) Oxygen saturation in Arterial blood

226

1119

2.22

23.98

7.6

6.7

95.23

95.83

0.78

216

1077

(3003181) Sodium [Moles/volume] in Urine

227

3.63

23.63

1.6

1.3

63.05

58.64

mmol/l

0.35

183

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

540

3635

1.80

23.44

3.7

2.3

62.72

82.48

u/l

0.41

499

3325

(3003396) Base excess in Arterial blood by calculation

245

1264

2.14

23.41

7.4

6.4

1.82

1.20

mmol/l

1.20

209

1007

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

325

3.17

23.39

1.7

1.5

0.07

iu/ml

0.00

(3002582) Erythrocytes [#/volume] in Urine

521

3479

1.81

23.16

4.8

3.1

19.34

71.83

e6/l

1.99

443

2626

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

632

4472

1.77

23.02

5.3

3.7

34.76

41.13

ng/l

0.33

511

3134

(3013512) EKG study

516

3447

1.80

22.83

5.0

4.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

982

7916

1.86

22.79

7.1

4.9

3375.33

2710.96

e6/l

0.14

110

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

108

385

2.96

22.75

1.6

2.2

37.61

37.70

g/l

0.05

339

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

104

363

3.02

22.74

1.5

2.3

0.01

0.00

g/l

0.49

335

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

168

4.01

22.60

7.3

4.7

1021.67

357.48

iu/ml

0.74

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

286

3.26

22.37

2.6

2.1

11.45

12.20

mg/l

0.30

264

(3030467) Casts [#/volume] in Urine by Automated count

487

3217

1.80

22.24

4.6

3.0

0.30

0.48

e6/l

1.75

414

2414

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

528

3575

1.78

22.15

4.1

3.1

1277.36

1240.18

ng/l

0.11

450

3037

(3037467) Urinalysis macro (dipstick) panel - Urine

998

8117

1.86

22.11

7.9

4.6

—

(3000991) Gas panel - Venous blood

194

932

2.26

22.05

10.4

6.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

192

3.73

21.63

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

112

420

2.82

21.50

1.4

1.2

0.26

1.05

u/ml

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

299

3.15

21.41

2.7

1.6

—

(36304419) Bacteria [Presence] in Urine

474

3146

1.78

21.05

4.5

3.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

113

435

2.74

20.63

6.0

4.3

25.49

24.88

mmol/l

1.31

105

407

(3019060) Gas panel - Arterial blood

159

727

2.34

20.23

4.7

4.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

247

1351

2.01

19.93

2.1

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1225

10830

2.31

19.57

9.9

5.1

2.90

1.93

mu/l

0.49

1144

9842

(3026008) Bacteria identified in Urine by Culture

588

4215

1.70

19.40

4.4

3.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

269

3.14

19.28

3.9

3.6

8.02

8.32

kpa

0.80

262

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

674

5016

1.68

19.24

2.5

2.0

97.01

95.64

pmol/l

0.29

343

2401

(3021447) Carbon dioxide [Partial pressure] in Venous blood

203

1052

2.09

18.92

6.3

3.3

5.98

5.79

kpa

1.54

198

1019

(3021960) Folate [Moles/volume] in Serum or Plasma

432

2863

1.75

18.86

1.8

1.5

23.05

21.38

nmol/l

0.36

363

2392

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

430

2851

1.74

18.72

3.4

2.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

346

2.84

18.67

1.4

2.3

0.00

g/l

-0.00

320

(3002032) Base excess in Venous blood by calculation

200

1038

2.09

18.55

6.3

3.4

2.52

1.97

mmol/l

1.23

182

867

(3018095) Leukocytes [#/volume] in Urine

574

4127

1.68

18.46

5.7

3.7

79.70

109.11

e6/l

0.61

465

2841

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

133

4.03

18.35

2.0

1.5

60.10

60.78

0.04

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

241

1351

1.95

17.99

2.1

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

3.97

17.98

1.5

—

(3021901) Oxygen saturation in Capillary blood

190

3.43

17.53

3.4

2.6

—

(40761536) Microorganisms panel - Urine sediment

185

954

2.09

17.41

5.5

4.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

343

2.77

17.29

1.4

2.3

0.00

g/l

-0.00

319

(3015235) Bicarbonate [Moles/volume] in Capillary blood

269

2.97

16.81

4.4

2.8

26.48

25.24

mmol/l

1.45

264

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

178

3.42

16.41

1.6

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

195

1047

2.01

16.39

8.4

6.7

117.37

119.32

g/l

0.68

190

1018

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

347

2.71

16.37

1.4

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

126

3.91

16.36

14.5

6.3

12.89

11.80

mg/l

0.62

117

(40768797) Stomach Pathology biopsy report

275

1667

1.81

15.94

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

152

3.59

15.92

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

253

2.95

15.56

1.8

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

190

3.26

15.47

1.8

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

260

2.91

15.40

1.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

128

3.77

15.23

1.4

1.5

—

(3035350) Ketones [Presence] in Urine by Test strip

731

5764

1.58

15.02

5.6

4.0

0.00

estimate

0.75

216

1130

(3009261) Glucose [Presence] in Urine by Test strip

739

5842

1.58

15.02

5.7

4.0

0.00

0.01

estimate

0.80

206

1023

(3002079) Sodium [Moles/time] in 24 hour Urine

6.86

14.89

1.4

1.3

167.35

143.87

mmol/24h

0.45

(3017143) Hepatitis C virus Ab [Presence] in Serum

191

1052

1.95

14.85

1.7

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

283

2.79

14.78

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

117

3.85

14.75

1.5

1.2

272.58

275.46

mosm/kgh2o

0.29

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

383

2.50

14.34

2.4

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

226

2.97

14.33

1.7

1.6

—

(3021788) Differential panel - Synovial fluid

205

3.07

14.26

2.1

1.6

—

(3021601) Nitrite [Presence] in Urine by Test strip

729

5794

1.56

14.10

7.3

5.4

0.00

estimate

0.50

208

1047

(3000494) Fungus identified in Specimen by Culture

224

1326

1.83

13.89

2.2

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

242

2.86

13.80

2.6

2.0

123.11

126.26

g/l

0.39

180

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

323

2.60

13.80

2.1

1.9

6.02

5.07

iu/l

0.35

104

(3026493) Urate [Moles/volume] in Serum or Plasma

406

2834

1.62

13.73

3.1

2.6

4012.89

6901.39

umol/l

0.65

344

2435

(3019550) Sodium [Moles/volume] in Serum or Plasma

1283

11865

2.42

13.47

33.8

16.3

139.23

139.63

mmol/l

4.64

1265

11560

(3033658) Prothrombin time (PT) actual/Normal

413

2909

1.60

13.40

5.5

3.7

91.35

91.07

0.08

403

2833

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

324

2.56

13.21

1.9

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

431

3079

1.59

13.12

6.6

4.4

0.00

estimate

1.08

206

1025

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1246

11412

2.09

13.05

31.7

14.1

21.67

22.92

mg/l

0.81

1124

8989

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

351

2.48

13.00

3.2

2.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

6.20

12.95

1.4

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1283

11892

2.38

12.92

34.1

16.4

3.92

3.96

mmol/l

7.11

1264

11567

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

371

2572

1.61

12.75

1.8

1.7

460.45

19063988.13

pmol/l

1.82

308

2093

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

5.18

12.71

2.6

2.7

903.58

1322.76

u/ml

0.60

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

381

2.40

12.61

3.2

2.2

416.46

965.95

ug/l

0.46

352

(3000012) Reticulocyte production index

146

3.30

12.53

4.8

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

378

2.39

12.37

3.2

2.0

12.49

12.69

nmol/l

0.07

333

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

370

2580

1.60

12.35

2.8

1.7

1.45

1.29

mg/l

0.28

287

1974

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

341

2.46

12.34

8.7

3.2

0.39

0.37

u/ml

0.21

202

(3041096) Erythrocytes [Presence] in Urine by Automated

419

3012

1.57

12.25

5.1

3.6

—

(3025941) Bacteria identified in Stool by Culture

122

613

2.09

12.20

1.5

1.2

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.36

11.98

1.3

1.2

24.04

14.61

u/l

0.90

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

218

1335

1.75

11.95

1.7

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

324

2.46

11.75

1.4

1.2

—

(3020891) Body temperature

451

2.21

11.39

5.9

4.3

—

(3042631) Mycobacterium sp identified in Specimen

146

3.15

11.20

2.3

2.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

560

4363

1.48

10.90

6.2

4.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

144

3.12

10.81

1.8

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

5.18

10.80

1.3

1.6

3.50

1.66

nmol/l

0.58

(3008152) Bicarbonate [Moles/volume] in Arterial blood

129

694

1.95

10.67

7.2

6.6

25.72

24.52

mmol/l

2.51

122

659

(36660697) Celiac disease serology panel - Serum

161

935

1.82

10.51

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

122

3.26

10.32

1.3

1.2

—

nmol/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

112

3.37

10.31

2.0

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

222

1421

1.67

10.27

3.2

2.1

178.51

119.95

ug/g

1.83

166

1105

(3015736) pH of Urine

584

4627

1.46

10.24

4.8

3.7

6.20

5.84

1.02

282

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

464

2.13

10.24

2.5

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

3.75

10.17

2.3

1.5

—

(3022145) Colonoscopy Study observation

209

1320

1.69

10.17

1.5

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

295

2036

1.57

10.03

1.3

48.20

37.49

iu/ml

0.49

102

678

(3017704) Immunofixation for Urine

4.09

9.99

1.6

1.7

—

(40768804) Tissue Pathology biopsy report

600

4796

1.45

9.96

2.3

2.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

424

2.15

9.83

2.4

1.8

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1181

10820

1.69

9.75

27.7

13.3

76.83

78.25

ml/min/173m2

1.20

1068

8839

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

137

3.05

9.75

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

833

7093

1.45

9.74

4.6

3.0

56.14

46.99

u/l

1.49

754

6520

(3021879) Hepatitis B virus core Ab [Presence] in Serum

123

676

1.90

9.55

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

292

2.36

9.51

2.3

1.7

17338.34

13129.93

e6/l

0.26

215

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

7.60

9.42

3.2

1.8

—

(40758558) Short blood count panel - Blood

404

3021

1.48

9.35

10.3

6.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

175

2.75

9.22

1.3

1.4

—

(3017732) Neutrophils [#/volume] in Blood

133

758

1.84

9.22

3.9

2.9

8.13

5.00

e9/l

0.45

610

(3026389) Candida sp identified in Specimen by Organism specific culture

159

2.83

9.13

2.2

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

223

2.53

9.12

2.0

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

182

2.70

9.10

1.8

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

182

2.70

9.10

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

122

3.09

9.01

3.6

3.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.88

8.98

2.3

2.6

45.34

41.21

0.56

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.88

8.98

1.9

1.4

4.74

7.20

u/l

1.35

(43055514) Macroprolactin [Presence] in Serum or Plasma

18.73

8.94

1.2

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

4.93

8.85

3.7

4.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

282

1979

1.54

8.79

3.6

2.6

1.17

1.36

e6/l

0.45

179

1076

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

310

2.26

8.72

1.4

1.2

5.70

2.92

u/ml

0.50

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

279

1958

1.53

8.68

1.3

32.99

12.12

u/ml

2.34

102

720

(3005322) IgE [Units/volume] in Serum or Plasma

122

690

1.84

8.67

1.6

1.2

135.77

193.90

u/ml

0.56

109

625

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

107

580

1.92

8.66

9.8

8.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.75

8.37

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

121

692

1.82

8.29

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

317

2.21

8.27

1.4

1.2

12.04

9.92

u/ml

0.10

(40761511) CBC panel - Blood by Automated count

1256

11810

1.82

8.11

29.3

13.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

3.80

8.09

3.0

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

367

2.10

8.09

1.8

1.4

264.00

294.05

ug/g

0.75

208

(3000060) B lymphocytes [#/volume] in Blood

6.33

8.02

1.6

2.0

242.00

293.33

e6/l

0.20

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

146

892

1.71

7.98

3.4

2.5

65.35

65.18

ml/min/173m2

0.02

373

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

460

3615

1.41

7.89

4.3

3.0

33.09

32.40

u/l

0.08

429

3430

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

333

2.13

7.72

1.4

1.2

31.80

33.87

u/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

249

2.30

7.64

1.3

1.2

18.70

5.73

u/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

183

2.51

7.47

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

3.03

7.38

1.5

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

3.03

7.38

1.5

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

3.03

7.38

1.5

1.4

—

(3042733) HLA Ab [Presence] in Serum

10.92

7.30

4.8

3.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

3.97

7.17

1.7

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

3.12

7.03

2.4

2.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

3.89

6.99

1.7

1.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.21

6.86

1.2

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.38

6.85

1.5

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

132

2.70

6.77

4.1

3.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

162

2.51

6.72

1.3

112.75

114.71

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.33

6.71

1.5

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

158

2.51

6.55

2.2

2.4

38.90

28.89

mg/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.16

6.46

1.9

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

113

2.78

6.40

2.5

2.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

3.01

6.40

2.2

1.5

26.91

33.48

0.40

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1275

12147

1.79

6.40

19.7

10.5

23.27

24.31

u/l

1.53

1237

11684

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

445

1.87

6.35

5.2

4.9

1.56

0.02

417

(21494434) Karyotype in Bone marrow

2.93

6.34

1.1

1.2

—

(3014271) Vancomycin [Susceptibility]

3.48

6.30

3.4

2.7

—

(3044941) Cell count panel - Synovial fluid

189

2.32

6.08

2.0

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

117

726

1.67

6.05

1.8

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

3.01

5.97

1.4

1.1

—

titre

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

101

2.81

5.91

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

209

1498

1.47

5.73

11.4

6.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.60

5.69

1.3

1.1

92.73

64.70

nmol/24h

1.04

(40761535) Cells panel - Urine sediment

143

948

1.57

5.67

5.5

3.7

—

(3012516) Albumin [Mass/volume] in Urine

423

3424

1.34

5.66

3.5

3.2

527.13

315.10

mg/l

0.33

261

2035

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

121

2.60

5.65

1.8

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

121

2.60

5.65

1.8

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.31

5.59

1.7

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.96

5.59

1.1

1.2

1.30

1.98

u/ml

0.20

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

111

2.65

5.50

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

16.09

5.41

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

359

1.88

5.37

3.8

3.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

7.91

5.35

1.5

1.1

69.70

79.80

ng/l

0.25

(3007930) Methemoglobin/Hemoglobin.total in Blood

441

1.79

5.32

5.3

5.0

0.92

0.90

0.11

413

(21494890) Protein electrophoresis panel - 24 hour Urine

113

2.60

5.32

1.9

2.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.31

5.31

1.2

1.1

1.09

1.06

ratio

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

148

1004

1.53

5.30

2.5

2.4

7.75

6.18

ug/l

0.38

119

862

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

182

1290

1.47

5.28

3.3

2.5

11.07

7.43

umol/l

0.62

152

1108

(46235355) HIV 1 and 2 tests - Meaningful Use set

213

1558

1.44

5.24

1.9

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

440

3615

1.32

5.24

4.2

3.7

9.63

7.37

mg/mmol

0.44

269

2116

(3048879) Bone marrow aspiration report

5.43

5.23

1.2

2.0

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1131

10584

1.41

5.20

7.0

5.9

40.34

39.89

mmol/mol

0.79

1024

9707

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

127

2.47

5.15

2.4

1.5

41.45

41.91

nmol/l

0.03

121

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

258

2.01

5.13

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

134

2.42

5.08

1.2

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

153

2.32

5.06

1.7

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

243

1833

1.40

5.01

4.3

2.8

3.02

3.40

e6/l

0.23

143

938

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

296

2313

1.36

4.91

4.6

3.8

450.13

268.51

ng/l

0.30

245

1839

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

156

2.28

4.85

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

119

2.47

4.81

1.6

1.4

0.35

0.36

nmol/l

0.02

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

176

2.19

4.81

1.3

1.2

20.86

21.52

u/l

0.04

151

(3020961) Endomysium IgA Ab [Titer] in Serum

541

1.67

4.76

1.1

1.2

—

187.93

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

238

2.01

4.74

3.5

3.4

85.05

1589.37

u/ml

0.79

221

(4035726) Immunohistochemistry procedure

151

1056

1.48

4.68

1.6

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

4.70

4.68

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.67

4.67

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

7.19

4.65

5.1

2.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

4.32

4.63

1.4

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

14.06

4.58

1.4

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.64

4.57

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.64

4.57

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.64

4.57

1.1

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.58

4.56

1.3

1.1

—

(40768443) Skin Pathology biopsy report

525

1.66

4.53

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

161

2.20

4.52

1.3

333.28

257.52

u/ml

0.73

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

161

2.20

4.52

1.7

1.2

6.43

3.71

u/ml

0.44

(3017569) Oxygen content in Arterial blood

3.29

4.47

1.8

3.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

147

1033

1.47

4.46

4.5

2.9

166.80

196.22

ng/l

0.75

137

944

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.09

4.41

1.5

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

112

2.44

4.40

1.7

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

163

2.18

4.40

1.7

1.2

2.17

3.76

u/ml

0.43

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

238

1.97

4.39

1.3

1.2

45.06

46.18

u/ml

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

170

2.15

4.37

1.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.91

4.34

1.3

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.91

4.34

1.4

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

2.61

4.32

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

5.53

4.29

1.3

1.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.98

4.29

1.6

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.98

4.29

1.6

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

126

2.33

4.28

1.7

1.5

—

(3036489) Thrombin time

425

1.71

4.26

3.1

2.1

22.30

21.40

0.36

379

(3002385) Erythrocyte distribution width [Ratio]

1059

9894

1.32

4.25

33.3

17.0

15.64

15.02

2.69

1051

9714

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

3.16

4.21

1.1

1.3

—

(3004451) EKG impression Narrative

3.16

4.21

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

228

1.96

4.19

8.4

3.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

5.27

4.14

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.55

4.14

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.55

4.14

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

267

1.87

4.04

1.2

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

197

2.01

4.00

1.3

1.5

—

(3002256) Pathology report gross observation

190

1428

1.38

3.99

1.3

—

(3047181) Lactate [Moles/volume] in Blood

342

1.76

3.98

6.5

6.1

1.20

1.29

mmol/l

0.39

304

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

6.46

3.98

5.7

2.1

—

(3003338) MCHC [Mass/volume]

877

9469

0.79

3.98

37.5

18.9

329.16

331.19

g/l

7.98

870

9389

(3019977) pH of Arterial blood

3.04

3.97

2.0

3.7

7.42

7.43

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.47

3.94

1.3

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

4.47

3.94

1.7

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

2.66

3.90

1.4

1.2

418.57

96.36

titre

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.29

3.83

1.3

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

101

2.40

3.83

2.9

2.3

0.53

1.26

g/24h

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

6.03

3.82

1.3

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

6.03

3.82

1.3

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

6.03

3.82

1.3

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

318

1.76

3.76

3.7

2.6

220.52

184.60

1.43

307

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.70

3.67

2.0

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

2.71

3.66

1.3

1.2

12.89

10.85

u/l

0.33

(3023323) Follitropin [Units/volume] in Serum or Plasma

405

1.66

3.66

1.4

1.3

27.53

30.56

iu/l

0.27

345

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

793

0.57

3.63

1.6

1.7

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

501

1.59

3.61

6.4

3.4

51.21

47.97

0.56

492

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

4.03

3.60

1.5

1.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

117

2.25

3.59

1.8

1.3

34.43

30.56

u/l

0.18

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

131

2.16

3.53

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.35

3.51

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

259

1.80

3.46

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

259

1.80

3.46

1.4

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

740

6703

1.23

3.45

3.1

2.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

194

1498

1.34

3.44

5.1

4.6

34.81

33.36

0.89

136

958

(3024932) HLA-DR beta [Type]

4.57

3.43

1.0

1.3

—

(3024471) HLA-A [Type]

4.57

3.43

1.0

—

(3045424) Erythrocytes [Presence] in Urine

195

1.92

3.41

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

789

0.58

3.38

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

114

2.22

3.36

1.5

1.4

374674.63

170533.99

e6/l

0.34

(3044889) 12 lead EKG panel

882

8155

1.23

3.31

4.7

3.9

—

(3009542) Hematocrit [Volume Fraction] of Blood

1295

12596

1.58

3.30

45.0

21.2

38.76

39.41

4.05

1213

11743

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.94

3.30

1.4

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.94

3.30

1.4

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

102

2.28

3.30

1.3

1.1

49.20

53.71

u/ml

—

(3028433) Virus identified in Specimen by Culture

3.04

3.25

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.76

3.24

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

103

2.25

3.23

1.2

—

(3016750) Collection duration of Urine

2.69

3.23

3.0

2.1

482.00

495.77

min

0.20

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.88

3.19

1.6

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.88

3.19

1.6

1.5

—

(3010813) Leukocytes [#/volume] in Blood

1295

12605

1.56

3.18

44.8

21.2

7.13

6.65

e9/l

11.51

1280

12226

(3024731) MCV [Entitic volume]

1295

12605

1.56

3.18

44.6

21.1

91.39

91.17

0.89

1285

12417

(42529406) Shigella sp [Presence] in Stool by Culture

374

1.63

3.17

1.4

1.1

—

(3035941) MCH [Entitic mass]

1295

12606

1.56

3.17

44.5

21.0

30.09

30.25

2.41

1285

12417

(3026361) Erythrocytes [#/volume] in Blood

1295

12607

1.56

3.15

44.8

21.1

4.30

4.41

e12/l

13.22

1280

12231

(3004775) Volume in Urine collected for unspecified duration

2.42

3.14

2.9

2.2

676.00

592.23

0.39

(3000963) Hemoglobin [Mass/volume] in Blood

1295

12610

1.56

3.11

45.2

21.3

128.48

132.66

g/l

20.82

1285

12423

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

368

1.63

3.11

1.4

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.30

3.11

1.7

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.82

3.09

1.6

1.5

—

(3007461) Platelets [#/volume] in Blood

1294

12602

1.54

3.06

44.9

21.2

266.11

255.05

e9/l

6.15

1280

12267

(3014765) Yersinia sp identified in Stool by Organism specific culture

372

1.61

2.99

1.4

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

10.03

2.98

1.6

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.73

2.92

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

4.73

2.92

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

151

1.94

2.81

1.6

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

4.46

2.79

1.4

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

153

1.91

2.72

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

153

1.91

2.72

1.7

1.4

—

(3039000) Anion gap in Blood

249

1.71

2.71

7.3

6.7

10.69

11.04

mmol/l

0.26

223

(3018572) Chloride [Moles/volume] in Blood

249

1.71

2.71

7.3

6.7

103.91

105.27

mmol/l

1.19

223

(3003327) Ova and parasites identified in Stool by Light microscopy

358

1.59

2.71

1.9

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

6.02

2.70

1.2

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.77

2.67

1.0

1.3

—

(3000492) Spirometry study

136

1036

1.35

2.66

1.9

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

108

795

1.39

2.62

1.2

140.99

147.56

iu/ml

0.06

297

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.68

2.60

2.1

1.5

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.74

2.55

3.8

2.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.62

2.53

1.1

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

150

1.88

2.52

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

150

1.88

2.52

1.6

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.99

2.49

1.0

1.1

2246.91

1607.14

miu/ml

1.47

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.99

2.49

1.7

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

2.33

2.49

1.6

11.20

12.20

umol/l

0.37

(3005988) Vibrio sp identified in Specimen by Organism specific culture

152

1.86

2.43

1.6

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

3.14

2.43

1.4

1.9

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.43

2.37

2.0

2.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

260

1.63

2.35

1.5

1.2

—

(40757494) Bilirubin.total [Moles/volume] in Blood

2.39

2.29

1.7

2.7

—

28.12

—

(3019174) dRVVT (LA screen)

4.63

2.27

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

4.63

2.27

1.0

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.29

2.25

2.8

1.8

18.51

9.53

ug/l

0.38

(3035880) pH of Pleural fluid

2.35

2.22

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.57

2.21

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

5.57

2.21

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.14

2.19

1.1

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

266

1.60

2.16

1.7

2.1

10329.05

2146.62

u/l

—

114

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.30

2.15

1.0

2.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.63

2.14

1.1

308.36

196.09

iu/ml

0.72

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

244

1.62

2.12

3.5

2.2

102.97

73.05

ug/min

0.21

143

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.72

2.07

2.7

1.2

11.20

9.01

ug/l

—

(4200892) Spirometry reversibility

109

837

1.33

2.07

1.6

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

359

3154

1.19

2.06

1.7

1.29

1.35

mmol/l

0.70

297

2640

(3044242) Glucose [Moles/volume] in Arterial blood

2.23

2.01

1.6

2.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.64

2.00

1.3

1.1

117.40

113.12

—

(3034426) Prothrombin time (PT)

2.82

2.00

1.2

1.4

—

(40768441) Liver Pathology biopsy report

2.09

1.97

2.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.13

1.92

2.1

1.5

79.40

79.76

umol/l

0.02

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.87

1.86

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

137

1106

1.27

1.81

2.9

2.2

32.94

34.62

u/l

0.17

125

934

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.34

1.74

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

3.86

1.71

4.4

5.4

—

(40768793) Breast Pathology biopsy report

382

0.60

1.71

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

203

1.59

1.69

1.5

1.4

—

(3022689) Creatine [Moles/volume] in Urine

2.81

1.65

1.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

1.98

1.64

1.0

321.67

290.03

mg/l

1.07

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

534

0.67

1.64

1.3

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.26

1.63

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

187

0.48

1.62

1.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

187

0.48

1.62

1.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

188

0.48

1.62

1.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

188

0.48

1.62

1.0

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.39

1.62

1.4

1.1

0.35

0.30

g/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.58

1.61

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.07

1.60

1.2

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.51

1.60

1.1

1.0

—

(44813793) Dust mix specific IgE antibody measurement

2.01

1.59

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.70

1.58

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

2.70

1.58

2.3

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

129

1.72

1.57

1.4

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.21

1.57

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.21

1.57

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

750

1.29

1.53

1.7

1.6

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.95

1.49

2.9

1.5

0.79

1.04

g/l

3.02

(3047007) Chlamydophila sp Ab [Presence] in Serum

147

1.64

1.48

1.4

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1150

11183

1.18

1.46

5.3

4.7

5.79

5.92

mmol/l

2.91

1019

10048

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

151

1266

1.22

1.45

3.2

4.0

54.86

21.68

ug/l

0.28

127

1025

(3005033) Fetal Nuchal fold Thickness US

154

0.45

1.43

1.0

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

155

0.45

1.42

1.0

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

157

1.60

1.41

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

111

1.72

1.39

2.6

2.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.08

1.38

2.0

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.95

1.38

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.95

1.36

2.2

2.0

11.52

18.89

umol/l

—

(3001019) Free T4 and TSH panel - Serum or Plasma

523

0.70

1.35

1.8

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

159

1.58

1.35

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

282

1.43

1.35

1.3

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

2.2

—

2.38

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.05

1.33

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

129

1.64

1.30

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

185

1.52

1.29

1.2

1.1

71.63

117.75

iu/ml

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.78

1.28

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.01

1.27

1.8

3.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

671

1.27

2.6

2.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.41

1.24

1.2

1.7

—

(3045788) Cell count panel - Pleural fluid

100

1.71

1.23

1.5

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

312

2817

1.14

1.23

6.1

3.9

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.01

1.23

1.7

1.8

16.62

207.09

ug/l

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

108

1.68

1.22

1.2

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

221

1.46

1.22

1.1

1.6

—

(3005570) Glucose [Moles/volume] in Urine

132

1.60

1.20

2.6

2.2

—

(3016879) Cocaine [Presence] in Urine

247

1.43

1.20

1.5

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

307

1.38

1.18

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

157

1.54

1.17

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

222

0.58

1.14

1.1

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

168

1.50

1.10

1.2

1.1

5.88

2.36

u/ml

0.32

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.39

1.09

1.0

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

122

1035

1.20

1.08

1.8

1.7

1.51

1.44

0.61

893

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.19

1.08

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

287

1.37

1.07

1.1

—

(4034850) Laboratory test

374

1.32

1.07

14.7

9.8

—

(3051651) Icteric interference index of Serum or Plasma

1.76

1.07

7.2

3.0

—

(3012441) Differential panel - Pleural fluid

1.66

1.07

1.3

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

1.51

1.06

1.2

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

105

1.63

1.06

1.1

1.2

—

(40768806) Pleura Pathology biopsy report

105

1.63

1.06

1.4

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.13

1.05

1.9

3.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.13

1.05

1.9

3.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

204

0.58

1.05

1.1

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.89

1.01

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

265

1.37

1.00

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

650

0.78

1.00

4.7

3.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

248

1.38

1.00

1.4

1.5

10.67

17.17

e6/l

0.29

188

(3014051) Protein [Presence] in Urine by Test strip

343

0.69

0.99

3.3

2.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

868

0.81

0.98

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

160

0.56

0.98

1.0

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

813

0.80

0.98

2.5

3.5

38.45

64.11

u/ml

0.54

785

(3027008) Opiates [Presence] in Urine

267

1.36

0.97

1.5

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

1.81

0.96

1.0

10.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

157

1.47

0.96

1.1

—

(3028300) Cannabinoids [Presence] in Urine

268

1.35

0.95

1.5

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.78

0.94

1.4

1.0

1.20

1.24

u/l

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.23

0.93

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

150

1.47

0.93

1.1

0.20

5.47

u/ml

—

(3047189) Immunofixation for 24 hour Urine

1.74

0.92

3.0

1.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

1.60

0.90

1.3

1.1

—

(3011288) Drugs identified in Urine by Screen method

168

1.44

0.90

2.2

1.7

—

(4281824) Cell count and differential, peritoneal fluid

169

0.59

0.88

1.1

—

(3019150) Specific gravity of Urine by Refractometry

278

2546

1.12

0.88

6.8

4.4

1.02

kg/l

0.19

389

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

129

0.54

0.88

1.3

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.00

0.87

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

177

1580

1.14

0.86

4.7

4.9

2.70

2.48

ug/l

0.19

152

1398

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

331

0.72

0.83

1.0

1.5

—

(3020650) Glucose [Presence] in Urine

1.88

0.82

1.3

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

156

1.42

0.79

2.1

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

1.67

0.78

1.4

1.3

134.75

143.65

nmol/l

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.67

0.78

1.0

1.2

—

83.50

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1094

10718

1.11

0.77

4.4

4.0

1.27

1.26

mmol/l

0.14

966

9642

(3004716) Salmonella sp identified in Stool by Organism specific culture

577

1.21

0.77

1.4

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.77

0.76

2.8

1.8

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.00

0.72

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.55

0.72

1.2

1.3

—

51.43

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1.58

0.71

1.0

201.83

323.04

ng/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.58

0.71

1.0

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.58

0.71

1.1

2.0

—

(3051611) Lipemic interference index of Serum or Plasma

135

1.41

0.69

5.7

2.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

161

1.37

0.68

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.67

0.68

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.53

0.66

1.2

1.5

—

(3003694) ABO and Rh group [Type] in Blood

322

3016

1.09

0.66

1.5

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.79

0.66

1.8

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.50

0.63

1.2

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.50

0.63

1.1

1.4

—

371.11

—

(1002224) Polysomnography panel

380

0.78

0.62

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1.55

0.62

1.5

1.3

0.50

1.15

promille

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.59

0.62

2.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.48

0.60

2.4

2.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1130

11124

1.09

0.60

5.0

4.4

1.57

1.54

mmol/l

1.80

1009

10101

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

200

1844

1.10

0.59

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

157

1.34

0.59

8.5

4.8

339.60

361.00

umol/l

0.18

138

(3049717) Cytology report of Urine Cyto stain

383

1.21

0.57

2.1

2.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

440

0.81

0.56

1.6

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

141

1.35

0.56

1.2

1.1

0.30

2.38

u/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.58

0.56

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

0.57

0.56

1.8

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.62

0.55

1.2

95.86

101.17

nmol/l

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

383

0.80

0.54

1.6

1.7

9.12

3.93

mg/l

0.71

285

(3029075) Extractable nuclear Ab panel - Serum

1.58

0.54

1.0

1.1

—

(3024263) Appearance of Synovial fluid

1.48

0.53

1.2

1.5

—

(3033799) Differential panel - Peritoneal fluid

1.54

0.53

3.2

1.8

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

790

1.14

0.52

2.8

2.4

61.59

25.85

au/ml

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.43

0.52

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.43

0.52

1.3

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

105

1166

0.89

0.51

1.4

1.7

—

(3016018) Differential panel - Cerebral spinal fluid

109

1.38

0.51

1.1

1.8

—

(3015183) Erythrocyte sedimentation rate

1.47

0.50

1.0

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

111

1.36

0.46

1.0

1.1

89.07

94.91

0.39

105

(1617658) Protocol used for examination of sentinel lymph nodes

142

0.70

0.46

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.45

1.0

25.00

48.77

ng/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1.43

0.45

1.0

705.80

656.04

ng/l

—

(3025130) Human papilloma virus identified in Specimen

138

1.31

0.45

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

247

1.22

0.44

2.0

1.7

0.87

0.82

nmol/l

0.15

203

(3027944) Amphetamines [Presence] in Urine

266

1.21

0.43

1.6

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

140

0.71

0.43

1.3

1.6

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.62

0.43

1.4

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.62

0.43

1.4

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.62

0.43

1.4

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.62

0.43

1.4

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

162

0.74

0.42

1.2

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.56

0.42

1.8

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.38

0.41

1.3

4.6

—

48.64

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.41

0.0

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.41

0.0

2.9

—

0.81

—

(3036180) Methadone [Presence] in Urine

1.47

0.40

1.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.47

0.40

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

150

1.27

0.40

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.2

—

0.68

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.43

0.39

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.37

0.38

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.37

0.38

1.1

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1.33

0.37

1.2

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.31

0.37

1.4

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

425

1.13

0.33

1.4

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1133

11217

1.06

0.33

5.0

4.5

4.65

4.72

mmol/l

1.10

1014

10259

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

370

0.86

0.32

1.7

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.35

0.31

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

203

1.19

0.30

1.7

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

163

0.80

0.29

1.1

1.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

106

0.75

0.29

3.9

2.1

13.91

13.15

—

106

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1156

11465

1.06

0.28

5.4

5.1

2.64

2.75

mmol/l

3.91

1035

10427

(3027456) Digoxin [Moles/volume] in Serum or Plasma

270

1.15

0.28

3.2

0.91

0.81

nmol/l

0.53

210

(3013139) Helicobacter pylori Ag [Presence] in Stool

803

0.92

0.28

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.32

0.28

1.6

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

626

0.91

0.27

1.1

1.0

—

(3045414) Leukocytes [Presence] in Urine

557

1.10

0.27

1.9

2.0

—

(4146454) Self-monitoring of blood glucose

131

1.22

0.27

3.6

2.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

878

0.93

0.24

2.3

2.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.32

0.23

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.22

0.22

1.2

1.1

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.00

0.21

0.0

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.21

0.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

1.16

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.54

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

0.21

0.0

2.0

—

0.03

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.21

0.0

1.3

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.4

—

12.00

—

(3001729) Color of Synovial fluid

0.00

0.21

0.0

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.21

0.19

1.3

1.1

13.73

4.27

u/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.21

0.19

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

147

1.16

0.18

3.3

2.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.76

0.17

1.2

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

152

0.85

0.17

1.4

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.71

0.16

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.18

0.16

1.6

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

112

1.16

0.14

1.3

1.0

3.43

3.18

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

441

1.07

0.14

2.2

2.9

476.67

547.50

u/ml

0.06

381

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

324

0.92

0.12

1.8

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

367

1.06

0.11

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

280

1.07

0.10

1.4

1.3

186.71

242.26

miu/ml

0.45

122

(40768795) Lymph node Pathology biopsy report

125

0.88

0.10

1.4

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

114

0.88

0.09

1.0

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

136

1.10

0.08

1.3

1.1

8.37

1.87

u/ml

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.82

0.08

1.4

1.56

1.58

g/l

—

(1761482) Bacteria [#/volume] in Urine by Culture

313

1.06

0.07

5.5

4.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

129

1263

1.02

0.07

4.2

4.3

21.82

21.19

0.18

589

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.85

0.07

1.3

1.4

7.16

8.81

mmol/l

—

(3011648) Oxygen content in Venous blood

1.06

0.07

2.2

4.0

10.47

10.80

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

265

0.94

0.07

4.8

3.9

26.18

24.97

mg/l

0.05

158

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

105

0.86

0.06

1.2

1.3

1.69

1.38

nmol/l

—

(1761868) Lipid panel - Serum or Plasma

361

3635

0.99

0.04

3.2

2.9

—

(3023410) Appearance of Cerebral spinal fluid

122

1.07

0.02

1.4

1.9

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

214

2153

0.99

0.02

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

471

1.02

0.02

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

913

1.01

0.01

3.0

0.75

0.73

ug/l

0.07

578

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

116

0.95

0.00

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

784

1.01

0.00

2.2

1.9

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

192

0.99

0.00

1.2

—

(3022621) pH of Urine by Test strip

818

1.00

0.00

4.1

3.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

307

1.01

0.00

1.1

—

(3008898) HLA-B27 [Presence]

373

0.99

0.00

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

0.89

0.00

7.6

4.4

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.87

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

20.58

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.0

2.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

37.89

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.91

0.00

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.0

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

-0.00

0.0

1.7

—

2.25

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.94

-0.00

1.0

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3051339) Copper [Moles/volume] in Blood

0.00

-0.00

0.0

1.3

—

15.52

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPOPARA and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPOPARA	1.606 [1.43, 1.81]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.323

During the follow-up period (1.1.1998 — 31.12.2019), 1113 out of 4177 females with E4_HYPOPARA died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPOPARA	2.355 [1.88, 2.95]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.022

During the follow-up period (1.1.1998 — 31.12.2019), 395 out of 1066 males with E4_HYPOPARA died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPOPARA.

N-year risk	Females	Males
1	0.192%	0.59%
5	1.074%	2.882%
10	2.494%	7.055%
15	4.443%	13.555%
20	7.481%	22.969%

Relationships between endpoints

↥

Index endpoint: E4_HYPOPARA – Hypoparathyroidism

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypoparathyroidism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints